Robert Siegel, Nora Tabea Sibert, Clara Breidenbach, Cihan Gani, Philipp Alexander Neumann, Stefan Rolf Benz, Stefan Post, Thomas Seufferlein, Vanessa Kolb, Matthias Behrend, Richard David Blossey, Jörg Bunse, Marc Dahlke, Ricarda Diller, Nikos Emmanouilidis, Thomas J. Ettrich, Jörg Fahlke, Sven Flemming, Björn Freitag, Martin Fuchs, Lars Haeder, Stephan Hollerbach, Jens Höppner, Mia Kim, Christian Klink, Jürgen Knuth, Stefan Koeppen, Jörg Köninger, Ernst Wolfgang Kolbe, Florian Kühn, Shueb Mussa, Robert Oehring, Sebastian Petzoldt, Pompiliu Piso, Christian Prause, Christian Prinz, Christoph Reißfelder, Maren Riechmann, Jörg-Peter Ritz, Jens Rolinger, Robert Rosenberg, Hubert Scheuerlein, Dustin Schilawa, Paul Magnus Schneider, Thilo Schwandner, Marco Siech, Daniel Steinemann, Oliver Stöltzing, Elke von Haeften, Dominik Weihs, Armin Wiegering, Christina Barbara Zielinski, Christoph Kowalski
{"title":"术前放疗对直肠癌患者报告预后的影响","authors":"Robert Siegel, Nora Tabea Sibert, Clara Breidenbach, Cihan Gani, Philipp Alexander Neumann, Stefan Rolf Benz, Stefan Post, Thomas Seufferlein, Vanessa Kolb, Matthias Behrend, Richard David Blossey, Jörg Bunse, Marc Dahlke, Ricarda Diller, Nikos Emmanouilidis, Thomas J. Ettrich, Jörg Fahlke, Sven Flemming, Björn Freitag, Martin Fuchs, Lars Haeder, Stephan Hollerbach, Jens Höppner, Mia Kim, Christian Klink, Jürgen Knuth, Stefan Koeppen, Jörg Köninger, Ernst Wolfgang Kolbe, Florian Kühn, Shueb Mussa, Robert Oehring, Sebastian Petzoldt, Pompiliu Piso, Christian Prause, Christian Prinz, Christoph Reißfelder, Maren Riechmann, Jörg-Peter Ritz, Jens Rolinger, Robert Rosenberg, Hubert Scheuerlein, Dustin Schilawa, Paul Magnus Schneider, Thilo Schwandner, Marco Siech, Daniel Steinemann, Oliver Stöltzing, Elke von Haeften, Dominik Weihs, Armin Wiegering, Christina Barbara Zielinski, Christoph Kowalski","doi":"10.1111/codi.70158","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aim</h3>\n \n <p>To prospectively evaluate the effect of preoperative radiotherapy followed by surgery versus surgery alone on patient-reported outcomes (PROs) 1 year after surgery.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>Prospective observational cohort study in 127 colorectal cancer centres. Patients with rectal cancer completed European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC-QLQ-C30) and Colorectal module (-CR29) questionnaires (thus providing PROs) before initialization of treatment [baseline (T0)] and at 12 months after surgery [follow up (T1)]. The PRO data together with sociodemographic information were linked to clinical data. Relevant confounders were identified using directed acyclic graphs. The effect of preoperative radiotherapy on selected PROs 12 months after surgery was estimated using adjusted tobit regression models.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of 1635 patients with rectal cancer for whom both baseline and follow-up PROs were available, 565 (35%) received preoperative radiotherapy. Twelve months after surgery, patients with surgery alone reported better scores for global health status/Quality of Life, urinary incontinence, faecal incontinence (patients without stoma), dyspareunia (female patients) and impotence (male patients) than did patients receiving preoperative radiotherapy. The statistically significant effects ranged between 33.20 (<i>p</i> < 0.001, <i>R</i><sup>2</sup> = 0.19) for impotence and 39.01 (<i>p</i> = 0.001, <i>R</i><sup>2</sup> = 0.10) for dyspareunia. For global health status/QoL and urinary incontinence, no statistically significant effect could be found.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Radiotherapy in addition to surgery negatively affects selected PROs 1 year after surgery in patients with rectal cancer. Compared with surgery alone, patients report profoundly impaired bowel and sexual function after preoperative radiotherapy. However, global health status/QoL was not affected statistically significantly. These results are an important argument for limiting preoperative radiotherapy to patients with a high risk of recurrence of rectal cancer and may facilitate informed decision-making.</p>\n </section>\n \n <section>\n \n <h3> Trial Registration</h3>\n \n <p>German Clinical Trial Registry Number DRKS00008724 (https://drks.de/search/de/trial/DRKS00008724).</p>\n </section>\n </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 7","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of preoperative radiotherapy on patient-reported outcomes in rectal cancer\",\"authors\":\"Robert Siegel, Nora Tabea Sibert, Clara Breidenbach, Cihan Gani, Philipp Alexander Neumann, Stefan Rolf Benz, Stefan Post, Thomas Seufferlein, Vanessa Kolb, Matthias Behrend, Richard David Blossey, Jörg Bunse, Marc Dahlke, Ricarda Diller, Nikos Emmanouilidis, Thomas J. Ettrich, Jörg Fahlke, Sven Flemming, Björn Freitag, Martin Fuchs, Lars Haeder, Stephan Hollerbach, Jens Höppner, Mia Kim, Christian Klink, Jürgen Knuth, Stefan Koeppen, Jörg Köninger, Ernst Wolfgang Kolbe, Florian Kühn, Shueb Mussa, Robert Oehring, Sebastian Petzoldt, Pompiliu Piso, Christian Prause, Christian Prinz, Christoph Reißfelder, Maren Riechmann, Jörg-Peter Ritz, Jens Rolinger, Robert Rosenberg, Hubert Scheuerlein, Dustin Schilawa, Paul Magnus Schneider, Thilo Schwandner, Marco Siech, Daniel Steinemann, Oliver Stöltzing, Elke von Haeften, Dominik Weihs, Armin Wiegering, Christina Barbara Zielinski, Christoph Kowalski\",\"doi\":\"10.1111/codi.70158\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Aim</h3>\\n \\n <p>To prospectively evaluate the effect of preoperative radiotherapy followed by surgery versus surgery alone on patient-reported outcomes (PROs) 1 year after surgery.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Method</h3>\\n \\n <p>Prospective observational cohort study in 127 colorectal cancer centres. Patients with rectal cancer completed European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC-QLQ-C30) and Colorectal module (-CR29) questionnaires (thus providing PROs) before initialization of treatment [baseline (T0)] and at 12 months after surgery [follow up (T1)]. The PRO data together with sociodemographic information were linked to clinical data. Relevant confounders were identified using directed acyclic graphs. The effect of preoperative radiotherapy on selected PROs 12 months after surgery was estimated using adjusted tobit regression models.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Of 1635 patients with rectal cancer for whom both baseline and follow-up PROs were available, 565 (35%) received preoperative radiotherapy. Twelve months after surgery, patients with surgery alone reported better scores for global health status/Quality of Life, urinary incontinence, faecal incontinence (patients without stoma), dyspareunia (female patients) and impotence (male patients) than did patients receiving preoperative radiotherapy. The statistically significant effects ranged between 33.20 (<i>p</i> < 0.001, <i>R</i><sup>2</sup> = 0.19) for impotence and 39.01 (<i>p</i> = 0.001, <i>R</i><sup>2</sup> = 0.10) for dyspareunia. For global health status/QoL and urinary incontinence, no statistically significant effect could be found.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Radiotherapy in addition to surgery negatively affects selected PROs 1 year after surgery in patients with rectal cancer. Compared with surgery alone, patients report profoundly impaired bowel and sexual function after preoperative radiotherapy. However, global health status/QoL was not affected statistically significantly. These results are an important argument for limiting preoperative radiotherapy to patients with a high risk of recurrence of rectal cancer and may facilitate informed decision-making.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Trial Registration</h3>\\n \\n <p>German Clinical Trial Registry Number DRKS00008724 (https://drks.de/search/de/trial/DRKS00008724).</p>\\n </section>\\n </div>\",\"PeriodicalId\":10512,\"journal\":{\"name\":\"Colorectal Disease\",\"volume\":\"27 7\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Colorectal Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/codi.70158\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colorectal Disease","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/codi.70158","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Impact of preoperative radiotherapy on patient-reported outcomes in rectal cancer
Aim
To prospectively evaluate the effect of preoperative radiotherapy followed by surgery versus surgery alone on patient-reported outcomes (PROs) 1 year after surgery.
Method
Prospective observational cohort study in 127 colorectal cancer centres. Patients with rectal cancer completed European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC-QLQ-C30) and Colorectal module (-CR29) questionnaires (thus providing PROs) before initialization of treatment [baseline (T0)] and at 12 months after surgery [follow up (T1)]. The PRO data together with sociodemographic information were linked to clinical data. Relevant confounders were identified using directed acyclic graphs. The effect of preoperative radiotherapy on selected PROs 12 months after surgery was estimated using adjusted tobit regression models.
Results
Of 1635 patients with rectal cancer for whom both baseline and follow-up PROs were available, 565 (35%) received preoperative radiotherapy. Twelve months after surgery, patients with surgery alone reported better scores for global health status/Quality of Life, urinary incontinence, faecal incontinence (patients without stoma), dyspareunia (female patients) and impotence (male patients) than did patients receiving preoperative radiotherapy. The statistically significant effects ranged between 33.20 (p < 0.001, R2 = 0.19) for impotence and 39.01 (p = 0.001, R2 = 0.10) for dyspareunia. For global health status/QoL and urinary incontinence, no statistically significant effect could be found.
Conclusion
Radiotherapy in addition to surgery negatively affects selected PROs 1 year after surgery in patients with rectal cancer. Compared with surgery alone, patients report profoundly impaired bowel and sexual function after preoperative radiotherapy. However, global health status/QoL was not affected statistically significantly. These results are an important argument for limiting preoperative radiotherapy to patients with a high risk of recurrence of rectal cancer and may facilitate informed decision-making.
Trial Registration
German Clinical Trial Registry Number DRKS00008724 (https://drks.de/search/de/trial/DRKS00008724).
期刊介绍：
Diseases of the colon and rectum are common and offer a number of exciting challenges. Clinical, diagnostic and basic science research is expanding rapidly. There is increasing demand from purchasers of health care and patients for clinicians to keep abreast of the latest research and developments, and to translate these into routine practice. Technological advances in diagnosis, surgical technique, new pharmaceuticals, molecular genetics and other basic sciences have transformed many aspects of how these diseases are managed. Such progress will accelerate.
Colorectal Disease offers a real benefit to subscribers and authors. It is first and foremost a vehicle for publishing original research relating to the demanding, rapidly expanding field of colorectal diseases.
Essential for surgeons, pathologists, oncologists, gastroenterologists and health professionals caring for patients with a disease of the lower GI tract, Colorectal Disease furthers education and inter-professional development by including regular review articles and discussions of current controversies.
Note that the journal does not usually accept paediatric surgical papers.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
